Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 130, Issue 13
September 28 2017
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
“MOR” engineering of antibodies in ALL
Anjali S. Advani
View Articletitled, “MOR” engineering of antibodies in ALL
INSIDE BLOOD COMMENTARY
STIMulation of signaling in neutrophils
Anika Stadtmann,Alexander Zarbock
View Articletitled, STIMulation of signaling in neutrophils

PERSPECTIVES

The promises and challenges of using gene mutations for patient stratification in follicular lymphoma
Clinical Trials & Observations
Oliver Weigert,David M. Weinstock
View Articletitled, The promises and challenges of using gene mutations for patient stratification in follicular lymphoma
Supplemental data

REVIEW ARTICLE

Cancer-associated pathways and biomarkers of venous thrombosis
Clinical Trials & Observations
Yohei Hisada,Nigel Mackman
View Articletitled, Cancer-associated pathways and biomarkers of venous thrombosis

HOW I TREAT

How I treat myeloma with new agents
Clinical Trials & Observations
Philippe Moreau
View Articletitled, How I treat myeloma with new agents

CLINICAL TRIALS AND OBSERVATIONS

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Clinical Trials & Observations
Elias Jabbour,Nicholas J. Short,Guillermo Montalban-Bravo,Xuelin Huang,Carlos Bueso-Ramos,Wei Qiao,Hui Yang,Chong Zhao,Tapan Kadia,Gautam Borthakur,Naveen Pemmaraju,Koji Sasaki,Zeev Estrov,Jorge Cortes,Farhad Ravandi,Yesid Alvarado,Rami Komrokji,Mikkael A. Sekeres,David P. Steensma,Amy DeZern,Gail Roboz,Hagop Kantarjian,Guillermo Garcia-Manero
View Articletitled, Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions
Ana Martín-Pardillos,Anastasia Tsaalbi-Shtylik,Si Chen,Seka Lazare,Ronald P. van Os,Albertina Dethmers-Ausema,Nima Borhan Fakouri,Matthias Bosshard,Rossana Aprigliano,Barbara van Loon,Daniela C. F. Salvatori,Keiji Hashimoto,Celia Dingemanse-van der Spek,Masaaki Moriya,Lene Juel Rasmussen,Gerald de Haan,Marc H. G. P. Raaijmakers,Niels de Wind
View Articletitled, Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions
Supplemental data
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients
Paula Río,Susana Navarro,Guillermo Guenechea,Rebeca Sánchez-Domínguez,Maria Luisa Lamana,Rosa Yañez,Jose A. Casado,Parinda A. Mehta,Maria Roser Pujol,Jordi Surrallés,Sabine Charrier,Anne Galy,José C. Segovia,Cristina Díaz de Heredia,Julián Sevilla,Juan A. Bueren
View Articletitled, Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34<sup>+</sup> cells from Fanconi anemia patients
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts
Denis M. Schewe,Ameera Alsadeq,Cornelia Sattler,Lennart Lenk,Fotini Vogiatzi,Gunnar Cario,Simon Vieth,Thomas Valerius,Sophia Rosskopf,Fabian Meyersieck,Julia Alten,Martin Schrappe,Martin Gramatzki,Matthias Peipp,Christian Kellner
View Articletitled, An Fc-engineered CD19 antibody eradicates MRD in patient-derived <em>MLL</em>-rearranged acute lymphoblastic leukemia xenografts
Supplemental data
Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype
Hye Sun Kuehn,Julie E. Niemela,Karthik Sreedhara,Jennifer L. Stoddard,Jennifer Grossman,Christian A. Wysocki,M. Teresa de la Morena,Mary Garofalo,Jingga Inlora,Michael P. Snyder,David B. Lewis,Constantine A. Stratakis,Thomas A. Fleisher,Sergio D. Rosenzweig
View Articletitled, Novel nonsense gain-of-function <em>NFKB2</em> mutations associated with a combined immunodeficiency phenotype
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

STIM1 and STIM2 cooperatively regulate mouse neutrophil store-operated calcium entry and cytokine production
Regina A. Clemens,Joshua Chong,Derayvia Grimes,Yongmei Hu,Clifford A. Lowell
View Articletitled, STIM1 and STIM2 cooperatively regulate mouse neutrophil store-operated calcium entry and cytokine production
Supplemental data

TRANSPLANTATION

Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
Clinical Trials & Observations
Yi L. Hwa,Rahma Warsame,Morie A. Gertz,Francis K. Buadi,Martha Q. Lacy,Shaji K. Kumar,David Dingli,Steve R. Zeldenrust,Nelson Leung,Susanne R. Hayman,Prashant Kapoor,Wilson I. Gonsalves,Taxiarchis V. Kourelis,Stephen Russell,Ronald S. Go,Miriam A. Hobbs,Amie L. Fonder,S. Vincent Rajkumar,Angela Dispenzieri
View Articletitled, Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
Supplemental data
Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant
Ezgi Karaesmen,Abbas A. Rizvi,Leah M. Preus,Philip L. McCarthy,Marcelo C. Pasquini,Kenan Onel,Xiaochun Zhu,Stephen Spellman,Christopher A. Haiman,Daniel O. Stram,Loreall Pooler,Xin Sheng,Qianqian Zhu,Li Yan,Qian Liu,Qiang Hu,Amy Webb,Guy Brock,Alyssa I. Clay-Gilmour,Sebastiano Battaglia,David Tritchler,Song Liu,Theresa Hahn,Lara E. Sucheston-Campbell
View Articletitled, Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant
Supplemental data

LETTER TO BLOOD

Increased risk of leukemia among sickle cell disease patients in California
Clinical Trials & Observations
Ann Brunson,Theresa H. M. Keegan,Heejung Bang,Anjlee Mahajan,Susan Paulukonis,Ted Wun
View Articletitled, Increased risk of leukemia among sickle cell disease patients in California
Supplemental data

BLOOD WORK

“Hof” in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma
Beenu Thakral,Sa A. Wang
View Articletitled, “Hof” in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma
Bilirubin inclusions in neonatal neutrophils
Adnan Qureshi,Naveed Akhtar
View Articletitled, Bilirubin inclusions in neonatal neutrophils

ERRATUM

Yoshimi A, Balasis ME, Vedder A, et al. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML. Blood. 2017;130(4):397-407.
View Articletitled, Yoshimi A, Balasis ME, Vedder A, et al. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML. <em>Blood.</em> 2017;130(4):397-407.
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals